Literature DB >> 10076566

Association of MTG8 (ETO/CDR), a leukemia-related protein, with serine/threonine protein kinases and heat shock protein HSP90 in human hematopoietic cell lines.

A Komori1, E Sueoka, H Fujiki, M Ishii, T Kozu.   

Abstract

A proto-oncogene, MTG8 (ETO/CDR), is disrupted in the t(8;21) translocation associated with acute myeloid leukemia, and the gene product, MTG8, is a phosphoprotein capable of cell transformation in concert with v-H-ras. To obtain insight into functional regulation of MTG8 by phosphorylation, we studied protein kinases that interact with, and phosphorylate, MTG8 in vitro. Recombinant MTG8 protein was first found to be associated with two serine/threonine protein kinases in cell extracts from both HEL cells and a leukemic cell line carrying t(8;21). A cytoplasmic protein kinase of 61 kDa (MTG8N-kinase) phosphorylated the amino-terminal of MTG8, and another of 52 kDa (MTG8C-kinase) phosphorylated the carboxyl-terminal domain. In addition, we demonstrated that heat shock protein 90 (HSP90) specifically binds to the amino-terminal domain of MTG8 in vitro and in vivo. Thus, our results shed new light on post-translational regulation of MTG8, perturbation of which, in AML1-MTG8 protein, probably contributes to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076566      PMCID: PMC5925983          DOI: 10.1111/j.1349-7006.1999.tb00666.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  37 in total

1.  Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

Authors:  C E Stebbins; A A Russo; C Schneider; N Rosen; F U Hartl; N P Pavletich
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

2.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

Review 3.  Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

Authors:  H Fujiki; M Suganuma
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

4.  ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.

Authors:  P F Erickson; G Dessev; R S Lasher; G Philips; M Robinson; H A Drabkin
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

5.  Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

Authors:  H Asou; S Tashiro; K Hamamoto; A Otsuji; K Kita; N Kamada
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

6.  The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.

Authors:  J J Westendorf; C M Yamamoto; N Lenny; J R Downing; M E Selsted; S W Hiebert
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.

Authors:  P F Erickson; M Robinson; G Owens; H A Drabkin
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

8.  Tumourigenicity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells.

Authors:  E Sueoka; N Sueoka; S Okabe; A Komori; M Suganuma; T Kozu; H Fujiki
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

9.  Gamma-phosphate-linked ATP-sepharose for the affinity purification of protein kinases. Rapid purification to homogeneity of skeletal muscle mitogen-activated protein kinase kinase.

Authors:  C M Haystead; P Gregory; T W Sturgill; T A Haystead
Journal:  Eur J Biochem       Date:  1993-06-01

10.  DEAF-1, a novel protein that binds an essential region in a Deformed response element.

Authors:  C T Gross; W McGinnis
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

View more
  3 in total

1.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

2.  The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.

Authors:  A M Melnick; J J Westendorf; A Polinger; G W Carlile; S Arai; H J Ball; B Lutterbach; S W Hiebert; J D Licht
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.

Authors:  Tomofusa Fukuyama; Toshio Kitamura; Tomoko Kozu
Journal:  Int J Hematol       Date:  2022-02-12       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.